Ever Source Wealth Advisors, LLC Viking Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 62 shares of VKTX stock, worth $4,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 52
19.23%
Holding current value
$4,268
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
478Shares Held
66.1MCall Options Held
6.24MPut Options Held
3.01M-
Vanguard Group Inc Valley Forge, PA10.1MShares$695 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$415 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$353 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$155 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$128 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.28B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...